Pregnancy, Lactation and Drugs in Dermatology - Systemic Therapy

Abstract

The increasing number of drugs used in dermatological a venereological practice demands from the dermatologist an updated knowledge on their safety. In the case of pregnant women or those breastfeeding, the decision on whether or not to prescribe a particular drug must be based on a thoughtful evaluation of the benefits for maternal health and the potential risks to fetus' or infant's well-being. Whenever these patients require topical or systemic therapies, most can be adequately treated with safe and effective options. The first part of this article discusses the most recent data on the safety of some of the most commonly used systemic drugs in the dermatological context, in women of childbearing age.